/주식/IMNM
IMNM

IMNM

USD

Immunome Inc. Common Stock

$15.410-0.950 (-5.807%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$16.360

고가

$16.800

저가

$15.060

거래량

0.74M

기업 기본 정보

시가총액

1.3B

산업

생명공학

국가

United States

거래 통계

평균 거래량

1.31M

거래소

NCM

통화

USD

52주 범위

저가 $5.15현재가 $15.410고가 $17.87

관련 뉴스

BusinessWire

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Immunome, Inc. (the "company") (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Nov. 3, 2025, the Compensation Committee of

더 보기
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BusinessWire

Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the 2nd Annual Guggenheim

더 보기
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
BusinessWire

Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance

Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, recently presented preclinical data showing its proprietary antibody-drug conjugate

더 보기
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance